eculizumab myasthenia gravis regain trial

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
eculizumab myasthenia gravis regain trial	0.01	0.6	2449	89	41
eculizumab	0.56	0.8	1718	81	10
myasthenia	1.2	0.2	3154	26	10
gravis	0.19	0.7	3975	37	6
regain	0.6	0.6	1626	60	6
trial	0.49	0.5	6717	19	5

Keyword	CPC	PCC	Volume	Score
eculizumab myasthenia gravis regain trial	0.14	0.9	5143	83
eculizumab for myasthenia gravis	1.99	0.9	2410	40
clinical trials for myasthenia gravis	0.34	1	1659	3
myasthenia gravis drug trials	0.1	0.5	6135	34
new research for myasthenia gravis	1.94	0.9	4611	19
myasthenia gravis new treatment 2023	1.9	1	1268	1
ravulizumab for myasthenia gravis	0.38	0.9	27	82
myasthenia gravis new treatment 2022	0.18	0.1	6099	16
satralizumab for myasthenia gravis	0.35	0.6	3137	96
latest research on myasthenia gravis	1.29	0.3	7234	31
myasthenia gravis experimental therapies	0.52	0.1	5908	82
myasthenia gravis case study	1.75	0.8	9376	46
current research on myasthenia gravis	1.45	0.8	5384	7
myasthenia gravis new treatment 2021	1.41	0.6	6354	40
myasthenia gravis new treatment 2020	0.46	0.1	7004	1
myasthenia gravis remission success story	1.76	0.9	813	77
newest treatment for myasthenia gravis	0.53	0.7	3818	12
experimental autoimmune myasthenia gravis	1.21	1	6568	4
eculizumab en miastenia gravis	1.93	0.1	284	60
myasthenia gravis latest treatment	0.53	1	7706	85
new treatment myasthenia gravis	0.82	0.7	5409	64
myasthenia gravis treatment updates	1.08	0.5	8248	14